Michael Abramoff, MD, PhD is the Founder and Executive Chairman of Digital Diagnostics, the autonomous AI diagnostics company which was the first in any field of medicine to get FDA authorization for an autonomous AI. In primary care, the AI system can instantaneously diagnose diabetic retinopathy and diabetic macular edema at the point of care. Dr. Abramoff’s achievements include development of the first ethical foundation for autonomous AI (2020), the first incorporation of AI into standards of care, as well as ultimately widespread payment for AI as a diagnostic service (2020). These achievements have already led to better outcomes for thousands of patients worldwide, through improved access, lower cost, and higher quality of care. As a Professor of Ophthalmology at the University of Iowa, Dr. Abramoff continues to see patients and has mentored dozens of graduate students, ophthalmology residents, and retina fellows. He currently chairs the Foundational Principles for Ophthalmic Imaging and Algorithmic Interpretation AI workgroup instigated by FDA.